These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 1307356

  • 1. Polyol pathway in the pathogenesis of diabetic complications and aldose reductase inhibitors.
    Madhu SV, Verma NP, Goel A, Kapoor VK.
    J Assoc Physicians India; 1992 Oct; 40(10):679-81. PubMed ID: 1307356
    [No Abstract] [Full Text] [Related]

  • 2. [The role of polyol pathways in formation of diabetic cataracts].
    Sabasiński K, Andrzejewska-Buczko J.
    Klin Oczna; 1997 Oct; 99(6):401-4. PubMed ID: 9685789
    [Abstract] [Full Text] [Related]

  • 3. [Clinical application of aldose reductase inhibitors--prevention and therapy of diabetic complications].
    Hotta N, Sakamoto N.
    Nihon Rinsho; 1987 Dec; 45(12):3010-27. PubMed ID: 3128677
    [No Abstract] [Full Text] [Related]

  • 4. Aldose reductase and its inhibition in the control of diabetic complications.
    Narayanan S.
    Ann Clin Lab Sci; 1993 Dec; 23(2):148-58. PubMed ID: 8457142
    [Abstract] [Full Text] [Related]

  • 5. Potential use of aldose reductase inhibitors to prevent diabetic complications.
    Zenon GJ, Abobo CV, Carter BL, Ball DW.
    Clin Pharm; 1990 Jun; 9(6):446-57. PubMed ID: 2114249
    [Abstract] [Full Text] [Related]

  • 6. Aldose reductase in diabetic cataracts.
    Kinoshita JH, Kador P, Catiles M.
    JAMA; 1981 Jul 17; 246(3):257-61. PubMed ID: 6787220
    [No Abstract] [Full Text] [Related]

  • 7. Effect of vanadate administration on polyol pathway in diabetic rat kidney.
    Saxena AK, Srivastava P, Kale RK, Baquer NZ.
    Biochem Int; 1992 Feb 17; 26(1):59-68. PubMed ID: 1616498
    [Abstract] [Full Text] [Related]

  • 8. Current status of aldose reductase inhibitors.
    Zimmerman BR.
    Diabetes Care; 1987 Feb 17; 10(1):123-5. PubMed ID: 3105984
    [No Abstract] [Full Text] [Related]

  • 9. Effect of sorbitol dehydrogenase inhibition on sugar cataract formation in galactose-fed and diabetic rats.
    Kador PF, Inoue J, Secchi EF, Lizak MJ, Rodriguez L, Mori K, Greentree W, Blessing K, Lackner PA, Sato S.
    Exp Eye Res; 1998 Aug 17; 67(2):203-8. PubMed ID: 9733586
    [Abstract] [Full Text] [Related]

  • 10. Aldose reductase inhibitors.
    Kirchain WR, Rendell MS.
    Pharmacotherapy; 1990 Aug 17; 10(5):326-36. PubMed ID: 2122421
    [Abstract] [Full Text] [Related]

  • 11. Polyol formation and NADPH-dependent reductases in dog retinal capillary pericytes and endothelial cells.
    Sato S, Secchi EF, Lizak MJ, Fukase S, Ohta N, Murata M, Tsai JY, Kador PF.
    Invest Ophthalmol Vis Sci; 1999 Mar 17; 40(3):697-704. PubMed ID: 10067973
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Polyol pathway in human epididymis and semen.
    Frenette G, Thabet M, Sullivan R.
    J Androl; 2006 Mar 17; 27(2):233-9. PubMed ID: 16278369
    [Abstract] [Full Text] [Related]

  • 16. Polyol pathway along the bovine epididymis.
    Frenette G, Lessard C, Sullivan R.
    Mol Reprod Dev; 2004 Dec 17; 69(4):448-56. PubMed ID: 15457514
    [Abstract] [Full Text] [Related]

  • 17. Erythrocytic sorbitol contents in diabetic patients correlate with blood aldose reductase protein contents and plasma glucose levels, and are normalized by the potent aldose reductase inhibitor fidarestat (SNK-860).
    Asano T, Saito Y, Kawakami M, Yamada N, Sekino H, Hasegawa S, Fidarestat Clinical Pharmacology Study Group.
    J Diabetes Complications; 2004 Dec 17; 18(6):336-42. PubMed ID: 15531183
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Redox state-dependent and sorbitol accumulation-independent diabetic albuminuria in mice with transgene-derived human aldose reductase and sorbitol dehydrogenase deficiency.
    Ii S, Ohta M, Kudo E, Yamaoka T, Tachikawa T, Moritani M, Itakura M, Yoshimoto K.
    Diabetologia; 2004 Mar 17; 47(3):541-548. PubMed ID: 14968292
    [Abstract] [Full Text] [Related]

  • 20. [Sorbitol, phosphoinositides and Na K-ATPase in the pathogenesis of diabetic complications].
    Greene DA, Sima AA, Lattimer SA.
    Journ Annu Diabetol Hotel Dieu; 1988 Mar 17; ():105-17. PubMed ID: 2845181
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.